• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[妊娠期间rt-PA溶栓治疗人工三尖瓣血栓形成]

[Thrombolytic therapy with rt-PA for thrombosis of tricuspid valve prosthesis during pregnancy].

作者信息

Azzano O, French P, Robin J, Quinson P, de La Bourdonnaye T, Champsaur G, Mellier G, Normand J, Bozio A

机构信息

Hôpital cardiologique, BP Lyon-Montchat.

出版信息

Arch Mal Coeur Vaiss. 1995 Feb;88(2):267-70.

PMID:7487277
Abstract

The authors report the case of a woman with thrombosis of a tricuspid Saint Jude prosthesis during the fourth month of pregnancy. A first course of thrombolytic therapy with rt-PA reestablished normal prosthetic valve function but was followed by a threatened abortion and severe uterine haemorrhage. An early rethrombosis of the prosthetic valve led to interruption of the pregnancy after failure of a second course of thrombolysis, and to replacement of the tricuspid valve prosthesis. This case illustrates the problems of pregnancy in women with mechanical cardiac prosthetic valves and the difficulties of treatment.

摘要

作者报告了一例在妊娠第四个月时三尖瓣圣犹达人工瓣膜发生血栓形成的女性病例。第一疗程使用重组组织型纤溶酶原激活剂(rt-PA)进行溶栓治疗恢复了人工瓣膜的正常功能,但随后出现了先兆流产和严重的子宫出血。人工瓣膜早期再次血栓形成导致在第二疗程溶栓治疗失败后终止妊娠,并更换了三尖瓣人工瓣膜。该病例说明了患有机械心脏人工瓣膜的女性在妊娠时所面临的问题以及治疗的困难。

相似文献

1
[Thrombolytic therapy with rt-PA for thrombosis of tricuspid valve prosthesis during pregnancy].[妊娠期间rt-PA溶栓治疗人工三尖瓣血栓形成]
Arch Mal Coeur Vaiss. 1995 Feb;88(2):267-70.
2
[Thrombolytic therapy with rt-PA of recurrent thrombosis in tricuspid valve prosthesis during pregnancy].[妊娠期三尖瓣人工瓣膜复发性血栓形成的rt-PA溶栓治疗]
Ann Fr Anesth Reanim. 1996;15(5):666-8. doi: 10.1016/0750-7658(96)82132-0.
3
[Thrombosis of mechanical tricuspid valve prosthesis: treatment by tissue-type plasminogen activator. Success after a 18 month-follow-up].[机械性三尖瓣人工瓣膜血栓形成:组织型纤溶酶原激活剂治疗。18个月随访后的成功案例]
Arch Mal Coeur Vaiss. 1994 Jun;87(6):813-7.
4
[Thrombolysis of prosthetic heart valve thrombosis using recombinant tissue plasminogen activator (rt-PA) in infancy and childhood].[重组组织型纤溶酶原激活剂(rt-PA)用于婴幼儿和儿童人工心脏瓣膜血栓溶解]
Z Kardiol. 2001 Mar;90(3):191-6. doi: 10.1007/s003920170183.
5
Thrombolytic therapy for the treatment of prosthetic heart valve thrombosis in pregnancy with low-dose, slow infusion of tissue-type plasminogen activator.低剂量、缓慢输注组织型纤溶酶原激活剂治疗妊娠合并人工心脏瓣膜血栓形成的溶栓治疗。
Circulation. 2013 Jul 30;128(5):532-40. doi: 10.1161/CIRCULATIONAHA.113.001145. Epub 2013 Jun 28.
6
Recombinant tissue type plasminogen activator treatment of thrombosed mitral valve prosthesis during pregnancy.重组组织型纤溶酶原激活剂治疗妊娠期二尖瓣人工瓣膜血栓形成
Can J Anaesth. 1997 Jul;44(7):735-8. doi: 10.1007/BF03013388.
7
[Asymptomatic postoperative thrombosis of a Saint Jude mitral valve prosthesis. Treatment by fibrinolysis with rt-PA].[圣犹达二尖瓣人工瓣膜术后无症状性血栓形成。rt-PA溶栓治疗]
Arch Mal Coeur Vaiss. 1991 Mar;84(3):413-7.
8
[Successful thrombolysis on an aortic valve prosthesis by plasminogen tissue activator during pregnancy].[孕期使用组织型纤溶酶原激活剂成功溶栓治疗人工主动脉瓣膜]
Arch Mal Coeur Vaiss. 1999 Apr;92(4):427-30.
9
Successful thrombolysis of st. Jude medical aortic prosthesis with tissue-type plasminogen activator in a pregnant woman: a case report.组织型纤溶酶原激活剂成功溶栓治疗一名孕妇的圣犹达医疗主动脉瓣假体:病例报告
Cardiol Rev. 2002 Nov-Dec;10(6):349-53. doi: 10.1097/00045415-200211000-00007.
10
Thrombolysis of prosthetic tricuspid valve thrombosis with human recombinant tissue plasminogen activator in an adolescent.青少年人工三尖瓣血栓形成采用重组人组织型纤溶酶原激活剂进行溶栓治疗。
Pediatr Cardiol. 2000 Jul-Aug;21(4):397-400. doi: 10.1007/s002460010092.

引用本文的文献

1
The use of thrombolytic therapy in pregnancy.妊娠期间溶栓治疗的应用。
Obstet Med. 2013 Sep;6(3):105-111. doi: 10.1177/1753495X13488771. Epub 2013 Jul 25.
2
Thrombolytic therapy in pregnancy.妊娠期溶栓治疗
J Thromb Thrombolysis. 2006 Jun;21(3):271-6. doi: 10.1007/s11239-006-5709-z.